From Name:
From Email:
To Name:
To Email:

Optional Message:

FDA approves new dosage strength of maintenance treatment for opioid dependence

from European Pharmaceutical Manufacturer Magazine

he U.S. Food and Drug Administration has approved a new dosage strength of buprenorphine and naloxone sublingual film as maintenance treatment for opioid dependence. With this announcement, Cassipa (buprenorphine and naloxone) sublingual film is available in a new dosage strength (16 milligrams/4 milligrams) and both brand name and generic versions are approved. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063